Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01063049 · ClinicalTrials.gov registry record · Phase 4
Gatorade/Miralax With or Without Bisacodyl Versus NuLytely for Colonoscopy Preparation
A Phase 4 study, sponsored by Gastroenterology Services.
- Completed
- Registry status
- Phase 4
- Development phase
- 600
- Enrollment target
NCT01063049: Completed Phase 4 study, sponsored by Gastroenterology Services.
NCT01063049 is a Phase 4 study that has completed, run by Gastroenterology Services. The registered enrollment target is 600 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (16% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01063049, a Phase 4 study, has completed, sponsored by Gastroenterology Services.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 600 participants
- Enrollment target
Study Summary
The purpose of this study is to compare Nulytely (or Trilyte) with a Gatorade and Miralax combination for cleaning out the colon before colonoscopy. A laxative pill called Bisacodyl may also be used with the Gatorade and Miralax to see if it helps with the clean out process. We are trying to find out if either of these methods is more acceptable to the patient and does a better job cleaning out the colon for a colonoscopy.
Primary Outcome
The Boston Bowel Preparation Scale measures cleanliness of the colon on a scale of 0 (very poor) to 9 (excellent).
Interventions
- DRUG Placebo
- DRUG Bisacodyl
- DRUG NuLytely
- DRUG Gatorade/Miralax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-02 |
| Phase | Phase 4 |
What the finished NCT01063049 record still lists
NCT01063049 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (16% higher).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01063049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01063049 about?
NCT01063049 is a clinical study titled "Gatorade/Miralax With or Without Bisacodyl Versus NuLytely for Colonoscopy Preparation". The purpose of this study is to compare Nulytely (or Trilyte) with a Gatorade and Miralax combination for cleaning out the colon before colonoscopy. A laxative pill called Bisacodyl may also be used with the Gatorade and Miralax to see if it helps with the clean out process. We are trying to find ou...
What is the current status of trial NCT01063049?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 600 participants. The study started on 2010-02. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01063049?
The interventions under investigation include: Placebo (DRUG), Bisacodyl (DRUG), NuLytely (DRUG), Gatorade/Miralax (DRUG).
Who is sponsoring clinical trial NCT01063049?
This trial is sponsored by Gastroenterology Services, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01063049's enrollment target sits among peer trials
600 137th of 2000 higher than 1,854 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia